Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.
Gökbuget N, Kelsh M, Chia V, Advani A, Bassan R, Dombret H, Doubek M, Fielding AK, Giebel S, Haddad V, Hoelzer D, Holland C, Ifrah N, Katz A, Maniar T, Martinelli G, Morgades M, O'Brien S, Ribera JM, Rowe JM, Stein A, Topp M, Wadleigh M, Kantarjian H.
Gökbuget N, et al. Among authors: rowe jm.
Blood Cancer J. 2016 Sep 23;6(9):e473. doi: 10.1038/bcj.2016.84.
Blood Cancer J. 2016.
PMID: 27662202
Free PMC article.